How do I hire a fractional VP of Sales for an insurtech company in 2027?

Fractional VP of Sales versus the alternatives you're actually choosing between

Founders usually frame this as "fractional or full-time," but in practice an insurtech company at seed through Series B is choosing among five distinct options, and the fractional VP of Sales is only one of them. Understanding what each option actually buys you is the difference between a productive engagement and six months of expensive coaching that produces no closed revenue.

The fractional VP of Sales is a senior sales leader working roughly 10 days per month across one to four clients. They manage your closers, run forecast calls, build deal stages and qualification criteria, coach individual reps on live opportunities, and produce a pipeline you can actually forecast against. They assume your go-to-market motion is broadly correct and their job is execution discipline. The typical monthly retainer sits in the eight-to-twelve-thousand-dollar range for that day count, occasionally lower for a pre-revenue insurtech where the leader is accepting equity in lieu of cash. Equity, when granted, is usually zero to half a point.

The fractional CRO is a strategically broader engagement — usually twelve to fifteen days per month, in the twelve-to-eighteen-thousand-dollar range — where the leader owns revenue as a system rather than sales as a function. That means pricing, packaging, channel selection, marketing alignment, customer success handoff, and partner negotiation all sit inside their remit. For insurtech specifically, this is the right shape when you are still deciding whether your growth engine is direct-to-consumer, broker-distributed, carrier-embedded, or some hybrid. Choosing wrong there costs a year; a VP of Sales cannot fix a channel selection error, because their mandate presumes the channel is already picked.

The sales consultant or advisor works two to four days a month, delivers diagnostics and recommendations, and does not own outcomes. This is cheap and often genuinely useful for a founder who is still selling personally and wants a second opinion on the funnel, but nobody should confuse it with leadership. Nothing gets built. Nothing gets managed. The founder still runs the team.

The interim or "embedded" VP of Sales is a full-time-equivalent leader on a fixed six-to-nine-month term, usually because you are between permanent hires or recovering from a failed one. This costs meaningfully more than fractional and looks like a normal salary plus a completion bonus. It is the right call when the sales org already exists and is actively bleeding — you cannot stabilize a team of eight reps in ten days a month.

The full-time VP of Sales is the endgame for most insurtech companies above roughly three million in ARR with five or more quota-carrying sellers and a repeatable motion. Below that threshold the role is frequently a mis-hire, because the company cannot yet articulate what it wants the person to repeat.

There is a sixth path worth naming because insurtech founders reach for it more than founders in other verticals: hiring a carrier-side or broker-side executive directly, often someone with twenty years at a national carrier and deep relationships. The relationships are real. The startup sales execution usually is not. Someone who has spent two decades inside a carrier's distribution org typically has never built a pipeline from zero, never configured a CRM, and never run a weekly forecast against a number they had to defend. Pair that person with a fractional revenue leader who can build the machine around their relationships, or you will pay a senior salary for a rolodex you could have rented.

The comparison that matters most is the first two. A fractional VP of Sales manages an engine that exists. A fractional CRO builds the engine. Insurtech companies get this wrong in a predictable direction — they hire the cheaper VP of Sales, discover four weeks in that the real problem is the company has no working channel thesis, and burn the engagement on a diagnosis they could have bought upfront.

How to choose between them without guessing

The decision is mechanical if you answer four questions honestly before you post the role anywhere.

Question one: can you name your primary distribution channel and defend it with data? If your insurtech company has closed at least a handful of deals through a repeatable route — a broker network, an embedded partner, an outbound motion into carrier innovation teams — and you can describe the buyer, the cycle length, and the objection pattern, you have a motion. Hire the VP of Sales. If you have scattered logos closed by the founder through personal network and no pattern, you do not have a motion, and a VP of Sales will spend your money discovering that.

Question two: how many people report into the role? Zero to two sellers is a coaching and building job, and ten days a month is genuinely enough. Three to six sellers is the honest ceiling for fractional — beyond that, one-on-ones, deal reviews, ramp support, and territory management consume more hours than the retainer covers, and the leader becomes a bottleneck instead of a multiplier. Seven-plus is an interim or full-time hire, full stop.

Question three: what is the compliance load on the sales motion? Insurance sales are regulated at the state level. Producer licensing varies by jurisdiction, commission arrangements have legal constraints in some states, and communications with prospects may need audit trails your CRM has to enforce. If your product touches licensed activity — quoting, binding, servicing policies — you need a leader who has operated inside that constraint. If you are selling pure software to carriers and never touch a licensed transaction, the compliance bar is lower and your candidate pool widens to fintech and regtech operators.

Question four: is the founder willing to stop being the top closer? This is the one nobody wants to answer. A fractional VP of Sales cannot be your primary closer on strategic accounts at ten days a month. If your biggest deals require the founder in the room, the fractional leader's job is to build the process around you, not to replace you — and the engagement should be scoped that way in writing. Founders who hire fractional leadership expecting to be freed from selling entirely are usually disappointed at day sixty.

Run this honestly and most seed-stage insurtech companies land on fractional CRO, most Series A companies with a working channel land on fractional VP of Sales, and most Series B companies discover they should have started a full-time search three months ago.

What insurtech makes harder, and what that changes about vetting

Generic RevOps advice about hiring fractional leadership assumes a SaaS buying cycle: a champion, an economic buyer, maybe a security review, thirty to ninety days. Insurance breaks most of those assumptions, and your vetting has to reflect it.

The buying committee is larger and stranger. A carrier deal can involve an innovation team that wants to buy, an actuarial team that needs to validate the model, a compliance officer who can veto, a procurement group with vendor-risk requirements written for a different era of software, and occasionally a state regulator whose approval gates the launch even after the contract is signed. Cycles of six to nine months are ordinary. A candidate who describes a thirty-day close as their norm has not sold here.

Distribution is multi-channel in ways that change the sales role itself. Direct-to-consumer insurtech is a performance-marketing business where the "sales" function is often conversion optimization and licensed agent staffing. Broker-distributed insurtech is a channel business where you sell to intermediaries who sell to end customers, and your real product is making the broker's life easier. Carrier partnership insurtech is enterprise B2B with a very small addressable market — there are only so many carriers — where losing one logo can cost a year of plan. Embedded insurtech means selling through non-insurance platforms: auto dealers, home warranty providers, gig marketplaces, property managers, lenders. Each of these is a different job. Ask which two the candidate has actually run, and disqualify anyone who claims all four.

Vet the playbook, not the résumé. The useful question is never "have you sold to insurance companies." It is: walk me through the last broker channel you built from zero — how many brokers did you recruit in the first quarter, what did the enablement look like, what was the activation rate, what killed the ones that went dark. Or: describe a deal where compliance blocked you and what you changed. Specific, procedural answers indicate real operating history. Vague answers about "relationship-driven selling in the insurance space" indicate someone who attended the conferences.

Check the technical floor. Your fractional leader does not need to be a Salesforce administrator, but at an early-stage insurtech company they will need to build the pipeline report, clean the CRM data, and write the first sequences themselves — there is no RevOps team to delegate to. Ask which CRM they configured most recently and what the object model looked like. Salesforce dominates insurtech because of reporting and audit requirements; HubSpot is common at earlier stages. Ask how they have used revenue intelligence and sales engagement tooling, and whether they have run compliant sequencing where message content needed review. A candidate who answers "the ops team handled that" is describing a company stage you are not at.

Check references at your stage, not their most impressive stage. A leader who was VP of Sales at a five-hundred-person carrier and also did two years at a Series A insurtech should be referenced primarily on the Series A work. Call three founders. Ask one question that separates the good from the plausible: did they leave behind a repeatable process, or did they personally close a few deals and leave the team where it was? You want a process. Deals close either way; process is what you are renting.

Costs, timelines, and what the money actually buys

Pricing for fractional revenue leadership is driven by three variables: scope, days per month, and your company's stage.

Scope. A pure sales-management scope — coaching, forecasting, pipeline hygiene, deal strategy — prices below a CRO scope that also covers marketing alignment, pricing, partner negotiation, and customer success handoff. The gap is meaningful, roughly the difference between the eight-to-twelve and twelve-to-eighteen thousand ranges, and it exists because the CRO scope requires decisions that change the company rather than decisions that change the quarter.

Days per month. Most fractional engagements run ten to fifteen days. Ten days is two-and-a-half days a week equivalent and supports a weekly forecast call, a weekly pipeline review, individual coaching for a small team, and meaningful build work on process or playbook. Fifteen days adds capacity for partner conversations, hiring, and direct participation in strategic deals. Below eight days a month you are buying advice, not leadership, and you should price and scope it as advisory.

Stage. Pre-revenue and sub-half-million ARR insurtech companies often negotiate lower cash retainers because the leader is accepting equity risk and the operational surface is small. Companies past two million ARR pay toward the top of the range, because the expectation shifts from "help us figure it out" to "close deals while building process," and both have to happen simultaneously.

Bonuses and equity. A performance component of roughly five to ten percent of the retainer base, tied to net new ARR or qualified pipeline created, is common and useful — it keeps the leader oriented toward output. Equity typically runs a quarter point to one point, with a one-year cliff and multi-year vest, and should be explicitly tied to engagement duration so a three-month departure forfeits everything unvested. Going above one point means you are effectively bringing on a co-founder, and you should structure and title it that way rather than pretending it is a vendor relationship.

What you should expect on the timeline. Weeks one and two produce a written assessment: pipeline audit, CRM data quality, current process, team capability, and a ninety-day plan. If you do not have a written document at day fourteen, that is your first escalation. Weeks three and four produce the playbook — deal stages with exit criteria, a qualification framework, forecast cadence, and whatever tooling gap needs closing. Month two is people work: hiring or reassigning, running the weekly forecast, coaching live deals, and beginning partner conversations if you have a channel motion. Month three is execution and handoff — the leader should be running your revenue meeting, personally involved in at least one strategic deal, and actively transferring the process to whoever owns it after they leave.

What you should not expect. Not a transformed number in ninety days. Insurtech cycles are long enough that a deal sourced in month one may not close until month seven, which means the honest ninety-day metric is pipeline quality and process maturity, not closed revenue. Founders who tie the entire engagement to bookings inside a quarter are measuring something the cycle length makes impossible, and they end up churning a competent leader for a structural reason.

The downstream cost nobody budgets for. A fractional leader who does the job well will surface work you then have to fund: a RevOps contractor to maintain what they built, a sales engineer for carrier technical reviews, a compliance review process, possibly a partner manager. Budget roughly one additional headcount's worth of downstream spend inside twelve months of a successful engagement. The alternative — building the machine and then starving it — is the most common way these engagements quietly fail six months after they end.

Running the engagement and planning the handoff from day one

Write the statement of work before you sign, and make it boring and specific. The failure mode for fractional engagements is not bad hiring, it is undefined scope: month one is exciting, month four is an open-ended retainer nobody wants to cancel and nobody can evaluate.

Structure the contract short. Three months, renewable monthly, thirty-day out for either party. This protects both sides. If the fit is wrong you find out cheaply, and a good leader will not object to it because they intend to earn the renewal.

Define deliverables as artifacts, not activities. "Improve the sales process" is unevaluable. "Deliver a documented deal-stage model with written exit criteria, a qualification framework applied to every open opportunity, and a weekly forecast running in the CRM by day forty-five" is evaluable. Every phase of the ninety days should end with something you could hand to a new hire.

Set the meeting cadence explicitly. Weekly forecast call, weekly one-on-one with the founder, monthly written progress summary against the plan. The monthly written summary matters more than it sounds — it forces the leader to state what changed and creates the paper trail you will use to decide on renewal.

Name the handoff target on day one. Every fractional engagement ends. It ends by converting to a full-time hire, by extending into a longer part-time arrangement, or by the founder reabsorbing the function. Decide which you are aiming at before you start, and tell the leader — a good one will build toward that target deliberately. If the target is a full-time VP of Sales, the fractional leader should help write the job description, screen candidates, and onboard the successor, and that should be in the SOW as a named deliverable rather than a favor you ask at the end.

Watch for the three failure signals. First, the leader is closing deals but nothing is written down — you are renting a salesperson at leadership prices and will be back at zero when they leave. Second, the leader is producing beautiful documents but pipeline is not moving — common when someone from a large-company background lands in a startup and defaults to process design. Third, the leader has gone quiet on partner or channel work because it is slow and unglamorous; in insurtech that work is often where the actual leverage is, and it is the first thing to slip.

Sourcing, briefly, because it affects everything above. The strongest fractional revenue leaders are rarely on job boards. They come through revenue-leadership communities, RevOps practitioner networks, fractional-executive networks, and warm introductions from investors and board members — venture partners at insurtech-focused funds frequently know operators doing this work, and some do it themselves. Ask your existing cap table first. A candidate who arrives with an investor reference and three stage-matched founder references you can call is worth two candidates who arrive with a polished deck.

The adjacent scenario worth planning for. If your insurtech company is simultaneously building a broker or embedded channel and a direct motion, a single fractional leader will pick one and neglect the other — the skill sets and cadences genuinely differ. The workable pattern is one fractional CRO owning strategy and sequencing across both, with a channel-specific contractor or partner manager underneath, rather than two fractional VPs who quietly compete for the same founder attention.

Related questions

What's the difference between a fractional VP of Sales and a sales consultant?

A fractional VP of Sales owns outcomes, manages people, and runs the forecast at roughly ten days per month. A consultant delivers diagnostics and recommendations at two to four days and owns nothing operationally. If you need someone to run the weekly revenue meeting, you need the former.

Can a fractional VP of Sales work across competing companies?

They should not work with direct competitors, and your agreement should say so explicitly. Working across two or three non-competing companies is normal and often beneficial — pattern recognition across accounts is part of what you are buying. Get the non-compete scope in writing before signing.

How long should an insurtech fractional engagement last?

Start at three months, extend in ninety-day increments. Most insurtech companies run six to twelve months total, because carrier and broker cycles are long enough that meaningful results need more than one quarter. Beyond eighteen months, you are likely avoiding a full-time hire you already need.

Should the fractional leader also help hire my full-time VP?

Yes, and put it in the statement of work. They know the market, can screen for the specific insurtech distribution depth you need, and have an interest in leaving behind a working system. The alternative — searching alone after they leave — usually costs an extra quarter.

FAQ

How do I know if I need a fractional VP of Sales or a fractional CRO?

If you have a proven channel and just need someone to manage sellers and enforce forecast discipline, hire a fractional VP of Sales. If you are still deciding between direct, broker, carrier, and embedded distribution — or your pricing and packaging are unsettled — hire a fractional CRO. The CRO costs more and decides more; the VP of Sales executes inside decisions already made. Insurtech companies mis-select toward the cheaper option and lose a quarter discovering the mistake.

Can a part-time leader really be effective at ten days per month?

Yes, if "effective" means building process, coaching a small team, and running a credible forecast. No, if it means being the primary closer on your largest accounts. At ten days a month, roughly two and a half days a week, they can support three to six sellers meaningfully. Beyond that headcount, the math stops working and the leader becomes a scheduling bottleneck rather than a multiplier.

Does insurtech experience really matter, or is good sales leadership transferable?

Sales leadership fundamentals transfer; insurance distribution knowledge does not. A leader who has never encountered state-level producer licensing, carrier procurement timelines, or broker channel enablement will spend the first two months learning what a domain-experienced candidate already knows. Adjacent regulated verticals — fintech, healthtech, regtech — transfer reasonably well because the compliance-gated buying pattern is similar. Pure SMB SaaS backgrounds transfer poorly.

What should I pay, and how much equity is normal?

Retainers commonly run in the eight-to-twelve thousand range for a sales-management scope at ten days a month, and twelve-to-eighteen thousand for a CRO scope at twelve to fifteen days. Add a performance bonus of roughly five to ten percent of base, tied to net new ARR or qualified pipeline. Equity, when granted, typically runs a quarter point to one point with a one-year cliff and multi-year vest. Above one point you are structuring a co-founder relationship.

What happens when the ninety days end?

Three outcomes: extend in another ninety-day block with fresh deliverables, convert to a full-time hire with the fractional leader running the search, or wind down with the process handed to whoever owns revenue next. Decide the target before you start and write it into the SOW. The engagements that go badly are the ones that drift into an open-ended retainer nobody evaluates and nobody wants to be the person to cancel.

How do I measure success in an industry with six-to-nine-month cycles?

Measure leading indicators, not bookings. Qualified pipeline created, stage-conversion rates, forecast accuracy against the prior month's call, documented process artifacts, and rep ramp progress are all observable inside ninety days. Closed revenue from deals the fractional leader sourced will often land after the initial engagement window. Tying the whole evaluation to in-quarter bookings guarantees you churn competent leaders for structural reasons.

Sources

• Pavilion — community for revenue leaders, including practicing fractional executives
• RevOps Co-op — operations-focused practitioner community and resources
• Harvard Business Review — management research on executive hiring and leadership transitions
• First Round Review — practical guidance on hiring and scaling early-stage revenue teams
• SaaStr — go-to-market benchmarks and VP of Sales hiring frameworks
• NAIC — National Association of Insurance Commissioners, producer licensing and state regulation reference
• Insurance Information Institute — industry structure, distribution channels, and market data
• Bessemer Venture Partners — cloud and go-to-market benchmarks for early-stage companies
• OpenView — expansion-stage sales hiring and compensation research

Related on PULSE

• [When to hire your first VP of Sales](/knowledge.html)
• [Fractional CRO vs. full-time revenue leadership](/knowledge.html)
• [Building a broker channel from zero](/knowledge.html)
• [RevOps stack for regulated industries](/knowledge.html)
• [Sales compensation for long enterprise cycles](/knowledge.html)